mesalamine has been researched along with azoxymethane in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, LK; Kim, YS; MacGregor, DJ; Sleisenger, MH | 1 |
| Chang, WC; Clapper, ML; Cooper, HS; Coudry, RA; Devarajan, K; Gary, MA; Litwin, S; Lubet, RA | 1 |
| Caruso, R; Fantini, MC; Fina, D; Macdonald, TT; Monteleone, G; Pallone, F; Palmieri, G; Pellegrini, R; Sarra, M; Stolfi, C | 1 |
| Bertin, B; Buob, D; Chatelain, D; Colombel, JF; Cortot, A; Desreumaux, P; Dubuquoy, C; Dubuquoy, L; El-Jamal, N; Fumery, M; Langlois, A; Romano, O; Rousseaux, C | 1 |
| Dammann, K; Evstatiev, R; Gasche, C; Harpain, F; Khare, V; Kurtovic, A; Lang, M; Mesteri, I | 1 |
| Byeon, JS; Cho, EA; Chung, EJ; Do, EJ; Hwang, SW; Kim, JH; Kim, SY; Lee, HJ; Myung, SJ; Park, S; Park, SH; Ryu, YM; Yang, DH; Yang, SK; Ye, BD | 1 |
6 other study(ies) available for mesalamine and azoxymethane
| Article | Year |
|---|---|
Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Anticarcinogenic Agents; Azoxymethane; Cell Division; Colonic Neoplasms; Genes, APC; Humans; Indomethacin; Intestinal Mucosa; Intestinal Neoplasms; Mesalamine; Mice; Mice, Mutant Strains; Phenylhydrazines; Prodrugs; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2000 |
5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.
Topics: Animals; Azoxymethane; Colitis; Colorectal Neoplasms; Cyclooxygenase 2; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mesalamine; Mice; Random Allocation | 2008 |
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine.
Topics: Aminosalicylic Acids; Animals; Anticarcinogenic Agents; Azoxymethane; Benzamides; Carcinogens; Cell Death; Cell Division; Colitis; Colonic Neoplasms; Cyclin D1; Dextran Sulfate; eIF-2 Kinase; Endoplasmic Reticulum; Flow Cytometry; G1 Phase; Gene Silencing; HCT116 Cells; Humans; Mesalamine; Mice; Resting Phase, Cell Cycle; Xenograft Model Antitumor Assays | 2010 |
The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARĪ³.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Azoxymethane; Blotting, Western; Cell Proliferation; Colonic Neoplasms; Humans; Immunoenzyme Techniques; Intestinal Mucosa; Intestines; Male; Mesalamine; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, SCID; PPAR gamma; Tumor Cells, Cultured | 2013 |
PAK1 promotes intestinal tumor initiation.
Topics: Animals; Azoxymethane; beta Catenin; Carcinogenesis; Colonoscopy; Dextrans; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genotype; Heterozygote; Immunohistochemistry; Inflammation; Intestinal Neoplasms; Male; Mesalamine; Mice; Mice, Inbred C57BL; Mice, Knockout; p21-Activated Kinases; Signal Transduction | 2015 |
Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Azoxymethane; bcl-2-Associated X Protein; Cell Transformation, Neoplastic; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Interleukin-6; Macrophages; Male; Mesalamine; Mice, Inbred C57BL; Phenylhydrazines; Phosphorylation; Probiotics; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Time Factors | 2016 |